ADMA BIOLOGICS INC's ticker is and the CUSIP is 000899904. A total of 4 filers reported holding ADMA BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26 | -94.2% | 7,500 | -93.8% | 0.00% | – |
| Q2 2023 | $449 | -49.4% | 121,700 | -54.7% | 0.00% | -100.0% |
| Q1 2023 | $888 | -33.0% | 268,500 | -21.4% | 0.00% | 0.0% |
| Q4 2022 | $1,325 | -99.8% | 341,600 | +27.1% | 0.00% | 0.0% |
| Q3 2022 | $653,000 | +203.7% | 268,800 | +147.5% | 0.00% | – |
| Q2 2022 | $215,000 | +92.0% | 108,600 | +76.3% | 0.00% | – |
| Q1 2022 | $112,000 | -1.8% | 61,600 | -24.0% | 0.00% | – |
| Q4 2021 | $114,000 | +21.3% | 81,100 | +36.1% | 0.00% | – |
| Q3 2021 | $94,000 | -1.1% | 59,600 | -0.2% | 0.00% | – |
| Q2 2021 | $95,000 | -25.2% | 59,700 | +8157.3% | 0.00% | – |
| Q1 2021 | $127,000 | -55.1% | 723 | -50.2% | 0.00% | – |
| Q4 2020 | $283,000 | +253.8% | 1,453 | +329.9% | 0.00% | – |
| Q3 2020 | $80,000 | -61.5% | 338 | -52.6% | 0.00% | – |
| Q2 2020 | $208,000 | -70.3% | 713 | -70.7% | 0.00% | -100.0% |
| Q1 2020 | $700,000 | +11566.7% | 2,434 | +15112.5% | 0.00% | – |
| Q4 2019 | $6,000 | -96.6% | 16 | -96.0% | 0.00% | -100.0% |
| Q3 2019 | $178,000 | +249.0% | 401 | +199.3% | 0.00% | – |
| Q2 2019 | $51,000 | +15.9% | 134 | +13.6% | 0.00% | – |
| Q1 2019 | $44,000 | – | 118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 593,600 | $1,442,000 | 0.00% |
| SIMPLEX TRADING, LLC | 268,800 | $653,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JANE STREET GROUP, LLC | 93,100 | $226,000 | 0.00% |